Glycopeptides and nephrotoxicity (Q40495778)

21 September 2017

1 reference

title

Glycopeptides and nephrotoxicity (English)

1 reference

21 September 2017

Chow AW

1

1 reference

PubMed ID

7699153

21 September 2017

Azar RM

series ordinal

2

1 reference

21 September 2017

1 November 1994

1 reference

21 September 2017

Intensive Care Medicine

1 reference

21 September 2017

20 Suppl 4

1 reference

21 September 2017

S23-9

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01713979

21 September 2017

0 references

cites work

Vancomycin: an update

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Tubulointerstitial nephritis due to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Vancomycin enhancement of experimental tobramycin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Pharmacokinetics of vancomycin in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

A simplified dosing method for initiating vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Application of a Bayesian method to monitor and adjust vancomycin dosage regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

A review of the safety profile of teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Pharmacokinetics of teicoplanin in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713979

Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration

21 January 2018

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus osteomyelitis.

1 reference

12 December 2020

Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients

1 reference

12 December 2020

Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage

1 reference

12 December 2020

Mild nephrotoxicity associated with vancomycin use.

1 reference

12 December 2020

Vancomycin and nephrotoxicity

1 reference

12 December 2020

A prospective study of adverse reactions associated with vancomycin therapy

1 reference

12 December 2020

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

1 reference

12 December 2020

Toxicology of vancomycin in laboratory animals

1 reference

12 December 2020

Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for Dosage

1 reference

12 December 2020

Teicoplanin nephrotoxicity: first case report.

1 reference

12 December 2020

Individualized adjustment of vancomycin dosage: comparison with two dosage nomograms.

1 reference

12 December 2020

Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.

1 reference

12 December 2020

Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

An updated comparison of drug dosing methods. Part IV: Vancomycin

1 reference

12 December 2020

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients

1 reference

12 December 2020

Pharmacokinetics and Bioavailability of a New Formulation of Teicoplanin following Intravenous and Intramuscular Administration to Humans

1 reference

12 December 2020

Renal tolerance and pharmacokinetics of vancomycin in rats

1 reference

12 December 2020

Clinical pharmacokinetics of teicoplanin

1 reference

12 December 2020

Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance

1 reference

12 December 2020

Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.

1 reference

12 December 2020

Vancomycin therapy for methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin

1 reference

12 December 2020

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

1 reference

12 December 2020

Vancomycin toxicity: a prospective study

1 reference

12 December 2020

Effect of intravenous vancomycin on renal function

1 reference

12 December 2020

Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy

1 reference

12 December 2020

Vancomycin therapeutic drug monitoring: is it necessary?

1 reference

12 December 2020

Necessity of a loading dose when using vancomycin in critically ill patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01713979

1 reference

21 September 2017

1 reference

PubMed ID

7699153